[Headache and migraine].
Headaches are one of the most common disorders and symptoms in daily medical practice. There has been dramatic progress of knowledge in the fields of epidemiology, pathophysiology, acute treatment, and preventive therapy over the past 100 years. Triptans have been the breakthrough in the treatment of acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Treatment for chronic tension headache is still unsatisfying. Cluster headache is part of the group of trigemino-autonomic headaches. Headache from medication overuse plays an increasingly important role. New medical care structures such as integrated headache care provide better support for patients with chronic headache disorders.
Universitätsklinik für Neurologie, Universitätsklinikum, Hufelandstrasse 55, 45147, Essen, Germany. h.diener@uni-essen.de
H C
HC
Diener
M A
MA
Slomke
V
V
Limmroth
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D020773:Headache Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology; D018377:Neurotransmitter Agents / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D014363:Tryptamines / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D002121:Calcium Channel Blockers; D018377:Neurotransmitter Agents; D014363:Tryptamines